BREVAN HOWARD CAPITAL MANAGEMENT LP – Iovance Biotherapeutics, Inc. Transaction History
BREVAN HOWARD CAPITAL MANAGEMENT LP portfolio value:
$2.68M
portfolio value
BREVAN HOWARD CAPITAL MANAGEMENT LP quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +37.13% | 75.77K shares | 428K | $9.58 | 279.83K |
| Q2 2022 | share | Increase | 0.00% | 204.05K shares | 2.25M | $11.04 | 204.05K |